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Abstract
Non-steroidal anti inflammatory drugs which were primarily used for the treatment 
inflammation and pain have also shown anti-cancer activity in many studies. The 
mechanism of action of NSAIDs in cancer may involve cyclooxygenase (COX) 
dependent or independent pathways. According to studies, COX-2 is overexpressed in 
several cancers such as prostate, breast, nonsmall-cell lung, colon, and pancreas. 
Nimesulide is an NSAID with COX-2 inhibitory activity and investigations show that 
it could induce apoptosis in cancer. Previously, a library of compounds was synthesized 
using Nimesulide as a lead compound. However, they displayed different molecular 
targets: tubulin and heat shock protein 27 (HSP27). Since Nimesulide does not interfere 
with any of these proteins, the targets of it in cancer remain unclear. Therefore, it is 
necessary to identify the original anti-cancer targets of Nimesulide in order to 
understand the structure activity relationship that lead to target switching in the 
Nimesulide derivatives. For this purpose, a six carbon linker and biotin conjugated 
Nimesulide probe was designed and synthesized. A human prostate cancer cell line, 
LnCap, was used to perform protein pull-down assay in order to analyze the proteins 
that bind to the Nimesulide probe. This study provides insight into the structural 
interactions that are important for the anti-cancer activity which can be used to 
synthesize more potent analogs with the original target of Nimesulide.
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